These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3485443)

  • 1. Studies on immunological assay of vitamin-K dependent factors. III. A double monoclonal immunoradiometric assay for factor IX antigen.
    Mikami S; O'Brien DP; Mellars G; Goodall AH; Tuddenham EG
    Br J Haematol; 1986 Mar; 62(3):513-24. PubMed ID: 3485443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to human factor VII: a one step immunoradiometric assay for VII:Ag.
    Takase T; Tuddenham EG; Chand S; Goodall AH
    J Clin Pathol; 1988 Mar; 41(3):337-41. PubMed ID: 3360957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of normal factor IX detected by mouse monoclonal antibodies.
    Wallmark A; Ljung R; Nilsson IM; Holmberg L; Hedner U; Lindvall M; Sjögren HO
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3839-43. PubMed ID: 3873655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
    Mikami S; Tuddenham EG
    Br J Haematol; 1986 Jan; 62(1):171-81. PubMed ID: 3484635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassays of factor IX antigen using monoclonal antibodies.
    Yoshioka A; Giddings JC; Thomas JE; Fujimura Y; Bloom AL
    Br J Haematol; 1985 Feb; 59(2):265-75. PubMed ID: 3970858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
    Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
    Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of factor IX inhibitors by immunoradiometric assay.
    Ljung R; Holmberg L
    Acta Haematol; 1983; 70(5):307-11. PubMed ID: 6414224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two allotypes of factor IX present in haemophilia B.
    Ljung R; Wallmark A; Nilsson IM
    Scand J Haematol; 1986 Nov; 37(5):411-6. PubMed ID: 3810038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to an epitope on the heavy chain of factor IX missing in three hemophilia-B patients.
    Thompson AR
    Blood; 1983 Nov; 62(5):1027-34. PubMed ID: 6194835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on immunological assay of vitamin K dependent factors. II. Comparison of four immunoassay methods with functional activity of protein C in human plasma.
    Mikami S; Tuddenham EG
    Br J Haematol; 1986 Jan; 62(1):183-93. PubMed ID: 3753650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic studies of factor IX (Christmas factor). II. Immunoradiometric assay of factor IX antigen.
    Yang HC
    Br J Haematol; 1978 Jun; 39(2):215-24. PubMed ID: 678474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.
    Baglia FA; Sinha D; Walsh PN
    Blood; 1989 Jul; 74(1):244-51. PubMed ID: 2665835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL; Weinmann AF; Thompson AR
    J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of haemophilia B detected by immunoradiometric assay: implications for prenatal diagnosis.
    Ljung R; Holmberg L
    Pediatr Res; 1982 Mar; 16(3):256-8. PubMed ID: 7063280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII.
    Thomas JE; Peake IR; Giddings JC; Welch AN; Bloom AL
    Thromb Haemost; 1985 Feb; 53(1):143-7. PubMed ID: 3922077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.
    Sinha D; Koshy A; Seaman FS; Walsh PN
    J Biol Chem; 1985 Sep; 260(19):10714-9. PubMed ID: 3875611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A; Ohkubo Y; Nishimura T; Tanaka I; Fukui H; Ogata K; Kamiya T; Takahashi H
    Thromb Res; 1986 Jun; 42(5):595-604. PubMed ID: 3487139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.